Spruce Biosciences Inc. (SPRB)
NASDAQ · Healthcare
Spruce Biosciences Inc. Operating Income 2022–2025
Spruce Biosciences Inc. annual/quarterly operating income history and growth rate from 2022 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Spruce Biosciences Inc. operating income for the quarter ending September 30, 2025 was -8.2 M, a 12.53% decrease year-over-year.
- Spruce Biosciences Inc. operating income for the twelve months ending September 30, 2025 was -34.8 M, a 30.77% decrease year-over-year.
- Spruce Biosciences Inc. annual operating income for 2025 was -36.5 M, a 34.97% decrease from 2024.
- Spruce Biosciences Inc. annual operating income for 2024 was -56.2 M, a 8.00% increase from 2023.
- Spruce Biosciences Inc. annual operating income for 2023 was -52.0 M, a 9.96% increase from 2022.
- Spruce Biosciences Inc. annual operating income for 2022 was -47.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Spruce Biosciences Inc. Operating Income — FAQ
Spruce Biosciences Inc. (SPRB) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Spruce Biosciences Inc.'s operating income?
Spruce Biosciences Inc. (SPRB) reported operating income of -$37M for fiscal 2025.
Where can I see SPRB's operating income history?
The chart and table above show Spruce Biosciences Inc.'s operating income by year and by quarter, including the growth rate.